Form 4: Lamb Weston GC Spytek Reports Equity Awards
Insider Transaction Report
Lamb Weston's General Counsel and Chief Compliance Officer, Eryk J. Spytek, reported the acquisition of restricted stock units and employee stock options.
Summary
- Eryk J. Spytek, General Counsel & Chief Compliance Officer of Lamb Weston Holdings, Inc., reported changes in beneficial ownership.
- Acquired 11,726 Restricted Stock Units (RSUs) on February 6, 2026, which vest in tranches on February 16, 2027 (33%), February 15, 2028 (33%), and February 13, 2029 (34%).
- Acquired a total of 244,085 Employee Stock Options on February 6, 2026, consisting of 85,430 options at a $60 exercise price, 85,430 options at a $75 exercise price, and 73,225 options at an $85 exercise price.
- These stock options become 100% exercisable on February 6, 2029, and expire on February 6, 2031.
- Transferred 6,645 shares into a revocable trust and acquired 216.2 additional shares through a dividend reinvestment feature since the last report.
- Following these transactions, Spytek directly owns 26,800.3 common shares and indirectly owns 25,322 common shares via a revocable trust.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting standard executive compensation and alignment of interests, without indicating any immediate operational or financial shifts.
Positives
- The grant of 11,726 Restricted Stock Units (RSUs) aligns management incentives with long-term shareholder value.
- The grant of 244,085 Employee Stock Options provides a significant incentive for future performance, with exercise prices of $60, $75, and $85.
- The acquisition of 216.2 additional shares through a dividend reinvestment feature indicates continued investment in the company.
Negatives
- No direct negative transactions or disclosures are reported in this filing.
Risks
- No specific risks are mentioned in this Form 4 filing.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance, focusing solely on insider equity transactions.
Industry Context
StockSavvy.ai notes that equity grants to executive officers like General Counsel are standard practice across industries, particularly in consumer staples companies like Lamb Weston, to align management's interests with long-term shareholder value. These grants are part of typical executive compensation packages designed to incentivize performance and retention.
Comparison to Industry Standards
- Equity compensation packages, including RSUs and stock options, are a common component of executive remuneration in publicly traded companies, comparable to practices at peers such as Conagra Brands (CAG) or McCain Foods (private).
- The vesting schedules and option exercise prices are generally in line with market practices for similar roles and company sizes, aiming to retain key talent and motivate performance over multi-year horizons.
Related Party Transactions
- Transfer of 6,645 shares by the reporting person into the reporting person's Revocable Trust.
Stakeholder Impact
- Shareholders: The equity grants align the General Counsel's interests with long-term shareholder value, potentially encouraging decisions that benefit the stock price.
- Employees: This filing specifically details executive compensation and does not directly impact the broader employee base.
Next Steps
- The Restricted Stock Units will vest in tranches on February 16, 2027, February 15, 2028, and February 13, 2029.
- The Employee Stock Options will become 100% exercisable on February 6, 2029.
Key Dates
| Date | Description |
|---|---|
| 02/06/2026 | Date of earliest transaction for RSU and stock option grants. |
| 02/16/2027 | First vesting date for 33% of the Restricted Stock Units. |
| 02/15/2028 | Second vesting date for 33% of the Restricted Stock Units. |
| 02/13/2029 | Third vesting date for 34% of the Restricted Stock Units. |
| 02/06/2029 | Date when all employee stock options become 100% exercisable. |
| 02/06/2031 | Expiration date for all employee stock options. |
Recommendation
holdThis Form 4 filing reports routine equity compensation grants to an executive officer and does not provide new information that would significantly alter the fundamental investment thesis for Lamb Weston Holdings, Inc. While the grants align management incentives, they are standard practice and do not warrant a change in investment recommendation based solely on this disclosure.
Keywords
Lamb Weston, LW, Eryk J. Spytek, Form 4, Insider Transaction, Restricted Stock Units, RSUs, Stock Options, Equity Compensation, Beneficial Ownership, Corporate Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.